Humanin: A Tracking Guide for an Early-Stage Mitochondrial Peptide

Humanin is a 24-amino-acid peptide encoded within the mitochondrial 16S rRNA gene. It was discovered in 2001 in surviving neurons from Alzheimer's brain tissue and has since become one of several "mitochondrial-derived peptides" of interest in aging research. The data is mostly preclinical. Anyone using it is on the leading edge of speculation, not evidence.

This guide is for tracking honestly under that uncertainty.

What it does

In cell and animal models, humanin has been associated with:

• Protection against amyloid-beta toxicity
• Improved insulin sensitivity
• Anti-apoptotic signaling via the IGFBP-3 and BAX pathways
• Reduced oxidative stress markers

Circulating humanin levels decline with age in humans, and centenarians' offspring have shown higher levels. That is interesting; it is not a clinical endpoint.

Typical protocol shape

There is no established human protocol. Self-experimenter reports describe:

• 1-5 mg subcutaneous, daily or every other day
• Short defined cycles (4-8 weeks)
• Sometimes paired with other longevity-adjacent peptides (epitalon, MOTS-c)

Stacking obscures attribution. Run things alone if you actually want to know what they do.

What to track daily

• Dose, time, site
• Sleep quality
• Cognitive clarity (0-10) at fixed times
• Energy and mood
• Appetite and any GI changes

What to track weekly

• Subjective cognitive battery (a simple n-back or reaction-time app, used consistently)
• HRV trends if you wear a tracker
• Exercise recovery
• Bodyweight

Peptide IA's HRV import and custom cognitive-score fields make this kind of soft-endpoint tracking less hand-wavy.

Bloodwork worth doing

Standard panels do not measure humanin in commercial labs. What you can track:

• Fasting glucose and insulin, HOMA-IR
• HbA1c at 3 months
• hs-CRP
• Lipid panel
• Basic CMP and CBC for safety

Realistic expectations

• Effects, if real, are likely slow and subtle
• The signal-to-noise on cognitive and energy claims is bad
• Improvements in any subjective measure should be weighed against placebo and tracking bias
• There are no long-term human safety data

Common mistakes

• Stacking with three other peptides and crediting humanin
• Expecting dramatic, fast effects
• Drawing conclusions from a 2-week trial
• Ignoring sleep and training variables that swamp any subtle peptide signal

A tracking template

• Daily: dose, sleep, mood, energy, cognitive score
• Weekly: HRV averages, recovery, weight
• Monthly: fasting glucose and insulin, hs-CRP
• Pre/post cycle: full metabolic panel

Bottom line

Humanin is scientifically interesting and clinically unproven in humans. If you are tracking it, treat the experiment as exactly that, with defined start and stop dates and clear endpoints.

Peptide IA is an educational and self-tracking tool. Nothing in this post is medical advice. Doses mentioned reflect what is commonly reported in research literature — they are not recommendations. Always consult a qualified physician before starting, changing, or stopping any protocol.